Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OMGA

Omega Therapeutics (OMGA)

Omega Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMGA
DateTimeSourceHeadlineSymbolCompany
01/06/202406:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
31/05/202407:10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OMGAOmega Therapeutics Inc
30/05/202421:00GlobeNewswire Inc.Omega Therapeutics To Participate In Two Upcoming Investor ConferencesNASDAQ:OMGAOmega Therapeutics Inc
29/05/202421:00GlobeNewswire Inc.Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business OfficerNASDAQ:OMGAOmega Therapeutics Inc
08/05/202421:00GlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersNASDAQ:OMGAOmega Therapeutics Inc
06/05/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMGAOmega Therapeutics Inc
06/05/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
06/05/202421:00GlobeNewswire Inc.Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:OMGAOmega Therapeutics Inc
23/04/202421:00GlobeNewswire Inc.Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:OMGAOmega Therapeutics Inc
09/04/202421:00GlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlNASDAQ:OMGAOmega Therapeutics Inc
29/03/202400:15GlobeNewswire Inc.Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateNASDAQ:OMGAOmega Therapeutics Inc
06/03/202423:00GlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024NASDAQ:OMGAOmega Therapeutics Inc
10/02/202409:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
10/02/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
10/02/202408:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
06/01/202408:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
03/01/202408:05GlobeNewswire Inc.Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
12/12/202308:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
05/12/202308:00GlobeNewswire Inc.Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceNASDAQ:OMGAOmega Therapeutics Inc
28/11/202311:01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:OMGAOmega Therapeutics Inc
21/11/202322:00PR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:OMGAOmega Therapeutics Inc
21/11/202308:00GlobeNewswire Inc.Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
13/11/202323:00GlobeNewswire Inc.Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and FibrosisNASDAQ:OMGAOmega Therapeutics Inc
09/11/202323:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMGAOmega Therapeutics Inc
09/11/202323:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
09/11/202323:00GlobeNewswire Inc.Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:OMGAOmega Therapeutics Inc
08/11/202308:00GlobeNewswire Inc.Omega Therapeutics to Participate in The Jefferies London Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
31/10/202322:00GlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic ControllerNASDAQ:OMGAOmega Therapeutics Inc
16/10/202322:00GlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLCNASDAQ:OMGAOmega Therapeutics Inc
12/10/202307:00GlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023NASDAQ:OMGAOmega Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OMGA